• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Holding US, Inc., Announces Strategic Partnership with B-Temia Inc. to Revolutionize the Rehabilitation Market

    5/28/24 4:05:00 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH") (NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced a strategic partnership with B-Temia Inc. aimed at driving AI-based innovation and smart integral solutions in the rehabilitation market. Leveraging B-Temia's expertise in AI-based robotics development alongside DIH's smart integral solutions and broad robotic portfolios, this collaboration marks a significant step forward in enhancing the quality of life for individuals in need of functional rehabilitation and support.

    Under this partnership, DIH and B-Temia will join forces to integrate state-of-the-art technologies into smart integral solutions for a transformative effect to further enrich DIH's offerings and industry leadership. The integration of Keeogo™ Dermoskeleton™ into DIH's offerings will enable simultaneous con-current therapies that may benefit patients in both semi-acute and chronic phases effectively. The incorporation of Artificial Intelligence (AI) and Machine Learning (ML) will enhance these systems, leading to optimal performance and improved user experience. DIH plans to validate the integration concepts and launch in the US market initially prior to bringing the expanded integral solutions to customers and patients worldwide.

    Keeogo, developed by B-Temia, has garnered widespread acclaim for its innovative design and effectiveness in assisting individuals with mobility challenges. Through this partnership, DIH will have exclusive rights to market and sell Keeogo in Canada, the US and Mexico. This partnership not only expands DIH's product range but also reinforces its commitment to providing cutting-edge solutions through clinical integration to customers across the regions.

    "We are excited to embark on a transformative journey with B-Temia," said Jason Chen, Chairman and CEO of DIH. "This partnership not only enriches our smart integral solution concept and offers for more transformative effects to our customers, but also will lead to more innovative and close-looped AI & ML-enabled optimizations that may redefine possibilities in rehabilitation."

    "We are excited to join hands with industry Leader DIH in integrating the Keeogo Dermoskeleton product and our AI-based technology into the state-of-the-art DIH platforms sharing the same vision to improve patient outcomes," said David Quitman, Chief Executive Officer B-Temia.

    The partnership between DIH and B-Temia represents a synergy of expertise and innovation, poised to revolutionize the smart robotics solutions for rehabilitation landscape. Together, they are committed to advancing technology-driven solutions that promote independence, mobility, and quality of life for individuals worldwide.

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the functioning of millions of people with disability and functional impairments. DIH is a global solution provider in blending innovative robotic and virtual reality ("VR") technologies with clinical integration and insights. Built through the mergers of global-leading niche technologies providers, DIH is positioning itself as a transformative total smart solutions provider and consolidator in a largely fragmented and manual-labor-driven industry.

    DIH website: www.DIH.com

    About B-Temia Inc.

    B-Temia, a strategic partner of Wistron Medical Technology, is at the forefront of human mobility enhancement, specializing in the innovative field of Dermoskeletics™. B-Temia is committed to transforming the way people move through advanced technology that seamlessly integrates with human biomechanics. B-Temia leads in developing groundbreaking mobility solutions that enhance rehabilitation and improve users' quality of life, setting new standards in human performance augmentation.

    B-Temia website: www.b-temia.com

    For media inquiries, please contact [email protected]

    Investor Contact:

    Greg Chodaczek

    Gilmartin Group

    [email protected]



    Primary Logo

    Get the next $DHAI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

    NORWELL, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) received a notice on July 29, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq"), which stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Annual Report on Form 10-K for the period ended March 31, 2025 with the Securities and Exchange Commission ("SEC"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC. Under Nasdaq rules, the Company has 60 calendar days from the date of the notice to file its Annual Report on F

    8/1/25 4:30:00 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Director Baucus Max was granted 52,817 shares (SEC Form 4)

    4 - DIH HOLDING US, INC. (0001883788) (Issuer)

    12/9/24 4:03:26 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    SEC Filings

    View All

    SEC Form DEF 14A filed by DIH Holdings US Inc.

    DEF 14A - DIH HOLDING US, INC. (0001883788) (Filer)

    8/26/25 9:15:24 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form NT 10-Q filed by DIH Holdings US Inc.

    NT 10-Q - DIH HOLDING US, INC. (0001883788) (Filer)

    8/15/25 8:00:23 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form PRE 14A filed by DIH Holdings US Inc.

    PRE 14A - DIH HOLDING US, INC. (0001883788) (Filer)

    8/13/25 9:00:04 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Professor Nick Ward, M.D., to DIH Scientific Advisory Board

    NORWELL, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Professor Nick Ward, M.D. to its Scientific Advisory Board. Nick Ward, M.D., is a Professor of Clinical Neurology and Neurorehabilitation at the Institute of Neurology at University College London and at the National Hospital for Neurology and Neurosurgery in Lo

    7/15/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care